| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $1.04B | +4.7% |
| Cost of Revenue | $260.6M | +3.2% |
| Gross Profit | $777.1M | +5.3% |
| R&D Expense | $248.8M | +2.2% |
| SG&A Expense | $129.0M | +1.9% |
| Operating Income | $50.8M | +37.8% |
| Pre-tax Income | $62.6M | +81.9% |
| Income Tax | -$66.4M | -971.5% |
| Net Income | $129.0M |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $383.7M | -10.4% |
| Short-term Investments | $96.9M | +195.7% |
| Accounts Receivable | $281.5M | +6.4% |
| Current Assets | $842.2M | +4.4% |
| Total Assets | $1.24B | +2.8% |
| Current Liabilities | $679.3M | -5.1% |
| Long-term Debt | $370.8M | +0.4% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $318.7M | +7.0% |
| Investing Cash Flow | -$82.8M | -168.7% |
| Financing Cash Flow | -$272.9M | +31.2% |
| +381.8% |
| EPS (Basic) | $0.69 | +1050.0% |
| EPS (Diluted) | $0.67 | +1016.7% |
| Total Liabilities |
| $1.18B |
| -4.9% |
| Stockholders' Equity | -$431.1M | +17.7% |